Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2003; 8: 70
An in vitro radioligand binding assay at A1 and A2A adenosine receptors (ARs) was conducted with a fixed extract combination of valerian (Valeriana officinalis) and hop (Humulus lupulus) (Ze 91019) to investigate a possible mechanism for the pharmacological activity of the extract. Component extracts of valerian and hop were also individually investigated. The fixed combination Ze 91019 as well as the valerian extracts therein exhibited selective affinity to A1ARs (Ki = 0.15–0.37 mg/ml vs. [3H]CCPA). The same extracts exhibited partial agonist activity at the A1 adenosine receptor as indicated by a lower degree of stimulation of [35S] GTP γS binding in membrane preparations of CHO-hA1 cells compared with the full A1 AR agonist N6-cyclopentyladenosine (CPA). In addition, valerian extract inhibited cAMP accumulation in CHO-hA1 cell membranes. The partial agonistic activity at A1ARs may play a role in the sleep-inducing effect of the valerian.